Most biotechs and speculative stocks require an investor to look ahead farther than a single year. This company has lots of, (NO, tremendous) potential, given how dreadful and how widespread are the addictions it adreses. With more trial-successes and publicity, its drugs with take off ballistically. The potential is certainly there for the stocks to quadruple a year after it hits the jackpot and has its lead drug be the recipient of wild. well-earned and enthusiastic praise. What are the odds of this happening? I would day 60%. SO if there is a 60% chance for the stocks to quadruple and a 40% chance for the stock to drop back to $2, that translates to a stock reaching $32! I am long and quite comfortable with the match!